Åke Svensson
21 – 30 of 168
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Asymmetric contributions of seed and pollen to gene dispersal in the marsh orchid Dactylorhiza umbrosa in Asia Minor
(
- Contribution to journal › Article
-
Mark
European Task Force on Atopic Dermatitis : position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
(
- Contribution to journal › Letter
-
Mark
Intervention study to evaluate the importance of information given to patients with contact allergy : a randomized, investigator-blinded clinical trial*
(
- Contribution to journal › Article
-
Mark
Selection process of measures for core outcome set should utilize the highest methodology level and should be maximally free of bias. Comment on ‘IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan : a group discussion study’
(
- Contribution to journal › Letter
-
Mark
Penile intraepithelial neoplasia, penile cancer precursors and human papillomavirus prevalence in symptomatic preputium : a cross-sectional study of 351 circumcised men in Sweden
(
- Contribution to journal › Article
-
Mark
Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis : An international, cross-sectional study
(
- Contribution to journal › Article
-
Mark
Skin exposure to scented products used in daily life and fragrance contact allergy in the European general population - The EDEN Fragrance Study
(
- Contribution to journal › Article
- 2020
-
Mark
Hidradenitis Suppurativa in Sweden : A Registry-Based Cross-Sectional Study of 13,538 Patients
(
- Contribution to journal › Article
-
Mark
Validation of a questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix I
(
- Contribution to journal › Article
-
Mark
TREatment of ATopic eczema (TREAT) Registry Taskforce : protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
(
- Contribution to journal › Article